6-(4-((Tert-butoxy)carbonyl)piperazin-1-yl)pyridine-3-carboxylic acid → 6-(Piperazin-1-yl)pyridine-3-carboxylic acid dihydrochloride
反応式
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[CH:22]=[CH:21][C:17]([C:18]([OH:20])=[O:19])=[CH:16][N:15]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.[ClH:23].O1CCOCC1>O1CCOCC1>[ClH:23].[ClH:23].[N:11]1([C:14]2[CH:22]=[CH:21][C:17]([C:18]([OH:20])=[O:19])=[CH:16][N:15]=2)[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]1参加物
4
実験手順
6-[4-(tert-Butoxycarbonyl)piperazin-1-yl]nicotinic acid (934 mg) was dissolved in dioxane (12 ml), and 4 M hydrogen chloride/dioxane (7 ml) was added thereto, followed by stirring at room temperature overnight. The precipitated solid was collected by filtration to obtain 6-piperazin-1-yl nicotinic acid dihydrochloride (850 mg).
後処理
- filtrationThe precipitated solid was collected by filtration
出典と根拠
- ORDレコード
- ord-8719bf3edd92439d99020cb7dc727709
- 出典データセット
- uspto-grants-2014_08
- 特許番号
- US08802679B2
反応ノート
読み込み中…